This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kim BS, Kook H, Hwang TJ et al. Autologous peripheral blood stem cell transplantation using G-CSF combined conditioning in AML patients: delayed platelet recovery and frequent early relapse Bone Marrow Transplant 2000 26: 459–460
Harada M, Akashi K, Hayashi S et al. Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission Int J Hematol 1997 66: 297–301
Gondo H, Harada M, Miyamoto T et al. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia Bone Marrow Transplant 1997 20: 821–826
Kawano F, Kiyomawa T, Shinagawa K et al. An early phase II study of autologous peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission (in Japanese with an abstract in English) Jpn J Clin Hematol 1999 40: 1051–1057
Miyamoto T, Nagafuji K, Harada M et al. Quantitative analysis of AML 1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia Br J Haematol 1995 91: 132–138
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harada, M., Gondo, H. & Kawano, F. High-dose chemotherapy with autologous PDSCT as post-remission therapy for AML. Bone Marrow Transplant 27, 347 (2001). https://doi.org/10.1038/sj.bmt.1702786
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702786